FTAdviser latest:IFAs' confidence in US equities returns

The majority of IFAs now favour the American equity market, in a dramatic turnaround in confidence from this time last year.

Standard Life pays out £88.6m in interim dividends

Standard Life is set to dish out £88.6m in interim dividends to shareholders this year.

RWC Partners to launch convertible bond fund

RWC Partners is planning to roll out a convertible bond fund to take advantage of pricing anomalies in the asset class.

Inalytics assesses managers' success

Fund managers only ever get half their decisions right, according to Inalytics, a financial research firm that monitors equity managers.

New Star steps in to save property fund

Firm stops dealing in International Property Fund amid series of redemptions

Infrastructure sector bucks the trend, says Lipper

Study finds governments around the world are set to inject money into public works

Way takes on life settlements market

Way Fund Managers is breaking into the lucrative life settlements market by teaming up with EEA Fund Management to launch its own class of the $277m (£179m) Life Settlement fund.

Invista appoints Clerical Medical to launch UK property fund

Invista Real Estate Investment Management has appointed Clerical Medical to launch its UK Property fund.

Managers concerned over corporate bond prices

Investors making redemptions on their corporate bond fund holdings have received as little as 90 per cent of the official fund value as a result of the current market dislocation, fund management sources have revealed.

Veritas to reopen Asian fund to new investors

Veritas Asset Management has announced it is to reopen its Asian fund to new investors to take advantage of current pricing in Asian and Pacific markets.

Comments

Light at the end of the tunnel

We've run out of sellers and there are few buyers, but some positive unknowns are coming into play


Advertising


Comments

Patents plague biotechnology

Until the credit crunch affected equity markets over the summer, the biotechnology sector was having a great year. Biotech companies big and small - from Genentech to GeneLabs, and across the world; from ImClone in the US to Jerini in Germany - have now either been acquired or are under offer.


Comments

The dangerous side effects of deflation

Apart from falling asset prices, deflation can lead the economy into a trap



FT Adviser Gym: Fixed Income

Train your brain with the new Fixed Income workout sponsored by AXA Investment Management.

Start training here


FTAdviser  Jobs  RSS


FTAdviser Blogs

  • Z is for Zeros

    As Investors’ Alphabet draws to a close, could there be a more suitable word for it to end on ...